Bioventus Inc. logo

Bioventus Inc.

BVS | NASDAQ
Chart Builder DCF Calculator
$13.63
+$0.32 (+2.40%)
Sep 22, 2026, 1:29 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
51.24M 41.58M 36.96M 30.19M 43.93M 86.84M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 2.64M 29.29M 19.38M
Other Long-Term Assets
2.29M 1.89M 3.14M 405.98M 50M n/a
Receivables
128.3M 127.39M 122.79M 136.3M 124.96M 88.28M
Inventory
82.24M 92.48M 91.33M 84.77M 61.69M 29.12M
Other Current Assets
11.07M 14.16M 16.91M 16.89M 20.28M n/a
Total Current Assets
272.84M 275.61M 268M 272.58M 263.1M 211.79M
Property-Plant & Equipment
27.02M 33.52M 49.96M 44.15M 40.17M 21.84M
Goodwill & Intangibles
375.88M 412.19M 489.81M 647.31M 842.82M 241.45M
Total Long-Term Assets
410.72M 452.35M 542.91M 1.1B 962.76M 282.67M
Total Assets
683.56M 727.96M 810.91M 1.37B 1.23B 494.47M
Account Payables
10.93M 23.69M 23.04M 36.7M 16.92M 4.42M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
19.21M 27.34M 27.85M 33.06M 18.04M 15M
Other Current Liabilities
93.51M 51.13M 34.23M 151.07M 46.48M 20.86M
Total Current Liabilities
160.38M 210.4M 175.5M 304.02M 180.86M 122.59M
Long-Term Debt
278.95M 308.29M 367M 385.01M 339.64M 173.38M
Other Long-Term Liabilities
2.16M 23.1M 46.08M 269.15M 38.05M 50.98M
Total Long-Term Liabilities
294.73M 331.95M 414.3M 656.41M 511.21M 227.72M
Total Liabilities
455.11M 542.35M 589.79M 960.43M 692.07M 350.31M
Total Debt
311.35M 335.63M 394.85M 418.07M 357.68M 188.38M
Book Value
228.45M 185.6M 221.12M 412.22M 533.79M 144.16M
Book Value Per Share
3.31 2.84 3.53 6.71 11.74 3.82
Common Stock
83K 82K 79K 78K 75K 285.17M
Retained Earnings
-334.93M -355.08M -321.54M -165.31M -6.6M -144.54M
Comprehensive Income
-1.9M -2.57M 794K -110K 179K 1.61M
Shareholders Equity
184.11M 147.94M 173.59M 325.24M 458.92M 142.24M
Total Investments
n/a n/a n/a 2.64M 29.29M 19.38M

© 2026 bestshares.com. All rights reserved.